Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oligonucleotides: extrapolating from in vitro to in vivo.
Hartmann G, Bidlingmaier M, Jahrsdörfer B, Endres S. Hartmann G, et al. Among authors: bidlingmaier m. Nat Med. 1997 Jul;3(7):702. doi: 10.1038/nm0797-702a. Nat Med. 1997. PMID: 9212085 No abstract available.
Cytokines and therapeutic oligonucleotides.
Hartmann G, Bidlingmaier M, Eigler A, Hacker U, Endres S. Hartmann G, et al. Among authors: bidlingmaier m. Cytokines Cell Mol Ther. 1997 Dec;3(4):247-56. Cytokines Cell Mol Ther. 1997. PMID: 9740353 Review.
Risk factors associated with a low glomerular filtration rate in primary aldosteronism.
Reincke M, Rump LC, Quinkler M, Hahner S, Diederich S, Lorenz R, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Meisinger C, Holle R, Endres S; Participants of German Conn's Registry. Reincke M, et al. Among authors: bidlingmaier m. J Clin Endocrinol Metab. 2009 Mar;94(3):869-75. doi: 10.1210/jc.2008-1851. Epub 2008 Dec 30. J Clin Endocrinol Metab. 2009. PMID: 19116235
The diagnosis and treatment of primary hyperaldosteronism in Germany: results on 555 patients from the German Conn Registry.
Schirpenbach C, Segmiller F, Diederich S, Hahner S, Lorenz R, Rump LC, Seufert J, Quinkler M, Bidlingmaier M, Beuschlein F, Endres S, Reincke M. Schirpenbach C, et al. Among authors: bidlingmaier m. Dtsch Arztebl Int. 2009 May;106(18):305-11. doi: 10.3238/arztebl.2009.0305. Epub 2009 May 1. Dtsch Arztebl Int. 2009. PMID: 19547646 Free PMC article.
Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: a cross-sectional study.
Apostolopoulou K, Künzel HE, Gerum S, Merkle K, Schulz S, Fischer E, Pallauf A, Brand V, Bidlingmaier M, Endres S, Beuschlein F, Reincke M. Apostolopoulou K, et al. Among authors: bidlingmaier m. World J Biol Psychiatry. 2014 Jan;15(1):26-35. doi: 10.3109/15622975.2012.665480. Epub 2012 May 8. World J Biol Psychiatry. 2014. PMID: 22568586
Quality of life in patients with primary aldosteronism: gender differences in untreated and long-term treated patients and associations with treatment and aldosterone.
Künzel HE, Apostolopoulou K, Pallauf A, Gerum S, Merkle K, Schulz S, Fischer E, Brand V, Bidlingmaier M, Endres S, Beuschlein F, Reincke M. Künzel HE, et al. Among authors: bidlingmaier m. J Psychiatr Res. 2012 Dec;46(12):1650-4. doi: 10.1016/j.jpsychires.2012.08.025. Epub 2012 Sep 25. J Psychiatr Res. 2012. PMID: 23017810
365 results